Ajanta Pharma Limited Unclassified
FDA Approved Drugs

Ajanta Pharma Limited Unclassified

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

Unclassified
  • Total Records 12
  • Latest Approval Date -
  • Data Source FDA
  • First Approval Date -
All
191
View
Unclassified
12
View
Discontinued
42
View
RX
137
View
Company Overview

Company

Ajanta Pharma Limited Unclassified

Country

India

Social Profiles

Company Snapshot

Ajanta Pharma Limited Unclassified

98, Ajanta House, Charkop, Kandivili (West) Mumbai, 400 067, India

India

www.ajantapharma.com/ info@ajantapharma.com View on Map
FDA Approved Drug Records ( 12 records )
-
Unclassified Application: 217055

Drug Name

EMPAGLIFLOZIN

Product Number

1

Dosage Form

-

Strength

10MG

Approval Date

-

217055 / 1

Active Ingredient

EMPAGLIFLOZIN

Application Number

217055

Product Number

1

Dosage Form

-

Strength

10MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 217055

Drug Name

EMPAGLIFLOZIN

Product Number

2

Dosage Form

-

Strength

25MG

Approval Date

-

217055 / 2

Active Ingredient

EMPAGLIFLOZIN

Application Number

217055

Product Number

2

Dosage Form

-

Strength

25MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 220511

Drug Name

EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

5MG/1000MG

Approval Date

-

220511 / 1

Active Ingredient

EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE

Application Number

220511

Product Number

1

Dosage Form

-

Strength

5MG/1000MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 220511

Drug Name

EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

10MG/1000MG

Approval Date

-

220511 / 2

Active Ingredient

EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE

Application Number

220511

Product Number

2

Dosage Form

-

Strength

10MG/1000MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 220511

Drug Name

EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

12.5MG/1000MG

Approval Date

-

220511 / 3

Active Ingredient

EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE

Application Number

220511

Product Number

3

Dosage Form

-

Strength

12.5MG/1000MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 220511

Drug Name

EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE

Product Number

4

Dosage Form

-

Strength

25MG/1000MG

Approval Date

-

220511 / 4

Active Ingredient

EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE

Application Number

220511

Product Number

4

Dosage Form

-

Strength

25MG/1000MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 215220

Drug Name

SITAGLIPTIN AND METFORMIN HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

50MG/1000MG

Approval Date

-

215220 / 2

Active Ingredient

SITAGLIPTIN; METFORMIN HYDROCHLORIDE

Application Number

215220

Product Number

2

Dosage Form

-

Strength

50MG/1000MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 216516

Drug Name

SITAGLIPTIN AND METFORMIN HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

50MG

Approval Date

-

216516 / 2

Active Ingredient

METFORMIN HYDROCHLORIDE, SITAGLIPTIN

Application Number

216516

Product Number

2

Dosage Form

-

Strength

50MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 216516

Drug Name

SITAGLIPTIN AND METFORMIN HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

1000MG

Approval Date

-

216516 / 3

Active Ingredient

METFORMIN HYDROCHLORIDE, SITAGLIPTIN

Application Number

216516

Product Number

3

Dosage Form

-

Strength

1000MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 214784

Drug Name

SITAGLIPTIN PHOSPHATE

Product Number

1

Dosage Form

-

Strength

EQ 25MG BASE

Approval Date

-

214784 / 1

Active Ingredient

SITAGLIPTIN PHOSPHATE

Application Number

214784

Product Number

1

Dosage Form

-

Strength

EQ 25MG BASE

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 214784

Drug Name

SITAGLIPTIN PHOSPHATE

Product Number

2

Dosage Form

-

Strength

EQ 50MG BASE

Approval Date

-

214784 / 2

Active Ingredient

SITAGLIPTIN PHOSPHATE

Application Number

214784

Product Number

2

Dosage Form

-

Strength

EQ 50MG BASE

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 214784

Drug Name

SITAGLIPTIN PHOSPHATE

Product Number

3

Dosage Form

-

Strength

EQ 100MG BASE

Approval Date

-

214784 / 3

Active Ingredient

SITAGLIPTIN PHOSPHATE

Application Number

214784

Product Number

3

Dosage Form

-

Strength

EQ 100MG BASE

Approval Date

-

Regulatory Status

Unclassified

Related Databases
  • FDA Inspections
    3 View
  • EDQM CEP
    0 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    0 View
  • FDA Approved Drugs Database
    191 View
  • Drug Prices in Switzerland
    0 View
Drug Status Breakdown
12 total
  • Unclassified
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

EMPAGLIFLOZIN

Application Number

217055

Product Number

1

Active Ingredient

EMPAGLIFLOZIN

Dosage Form

-

Strength

10MG

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.